SRF share price: Today's buying in SRF was buoyed after the company reported an 11 per cent Y-o-Y increase in its consolidated net profit to ₹582.02 crore for the March quarter.
United Breweries share price fell 5 per cent and hit a 52-week low on Wednesday, after Q4FY26 results, flagged Iran war-driven cost pressures and weak margin outlook
The sentiment was further buoyed by the company's announcement of dividend rewards for shareholders
Raymond Realty reported a net profit of 161 crore, up 44 per cent from ₹112 crore in the year-ago period. In the Q3FY26, the company's net profit stood at ₹67 crore
Bank of Baroda Q4FY26 results preview: Profit may remain flat or decline as treasury losses, NIM pressure offset strong loan growth. Check estimates, dividend outlook.
Punjab National Bank reported a domestic NIM of 2.61 per cent for Q4FY26, as compared to 2.96 per cent in the corresponding quarter of the previous fiscal
Q4 execution was impacted by ₹5,000 crore revenue slippage due to supply chain disruptions in the Middle East and delays in water projects, indicating near-term execution headwinds.
SBI Q4FY26 preview: Profit may fall up to 12% due to weak treasury income. Brokerages share NII, loan growth, NIM and dividend expectations
Elara Capital has upgraded its rating to 'Accumulate' from 'Reduce', while Choice Institutional Equities has reaffirmed its 'Buy' rating following the Q4 results
Q4FY26 company results: Firms including Shree Cements, Godrej Consumer Products, PB Fintech, Blue Star, and Raymond Lifestyle are also to release their January-March earnings today
Brokerages tracked by Business Standard estimate Swiggy's net loss at an average of ₹857.56 crore year-on-year (Y-o-Y) from a loss of ₹971.66 crore
Stocks to Watch today, Wednesday, May 6, 2026: Vedanta, Zen Tech, Grasim Industries, PNB, and Emcure Pharma are among the top stocks to watch today
L&T posts marginal decline in Q4 profit due to base effect, while revenue grows 11% on strong order inflow; board recommends Rs 38 per share dividend
Mahindra & Mahindra reports a 42% rise in Q4 PAT to Rs 4,668 crore, driven by strong performance in auto, farm and services businesses, alongside steady growth in EVs
State-owned Punjab National Bank (PNB) on Tuesday reported a 14.4 per cent year-on-year rise in net profit to Rs5,225crore for the three months ended March 2026, driven by higher interest income. The lender had earned a net profit of Rs 4,567 crore in the year-ago period. However, the bank's total income fell to Rs36,319crore during the quarter under review from Rs36,705 crore a year ago, PNB said in a regulatory filing. Interest income grew to Rs32,157crore from Rs31,989crore in the fourth quarter of the previous financial year. On the asset quality front, the bank's gross Non-Performing Assets (NPAs) improved to 2.95 per cent of gross advances as compared to 3.95per cent by the end of March 2025. Similarly, net NPAs came down to 0.29 per cent from 0.4 per cent. The board also recommended a dividend of Rs 3 per equity share for FY 2025-26, subject to approval of shareholders at the ensuing Annual General Meeting of the bank.
BHEL's strong Q4FY26 performance and robust order book are offset by concerns over valuations, execution challenges, and sustainability of margin gains
Hero MotoCorp reports 26.1% rise in Q4FY26 net profit, driven by strong demand, GST rate rationalisation, and growth across domestic and global markets
NSE reports 8.3% rise in Q4FY26 consolidated profit to Rs 2,871 crore and sets aside Rs 84 crore provision for pending settlement applications with Sebi
Ajanta Pharma Ltd on Tuesday reported a 18.4 per cent rise in consolidated net profit at Rs 266.7 crore in the fourth quarter ended March 31, on the back of strong US generics revenue growth. The company had posted a consolidated net profit of Rs 225.26 crore in the corresponding period previous fiscal, Ajanta Pharma Ltd said in a regulatory filing. Consolidated revenue from operations in the fourth quarter stood at Rs 1,421.64 crore as against Rs 1,170.41 crore in the year-ago period, it added. During the quarter branded generics in the markets of India, Asia and Africa clocked a combined revenue of Rs 859 crore as compared to Rs 805 crore in the year-ago period, up 7 per cent. US generic revenue was at Rs 505 crore as compared to Rs 325 crore in the same period a year ago, up 56 per cent, the company said. Total expenses in the fourth quarter were higher at Rs 1,135.96 crore as compared to Rs 919.11 crore in the same period a year ago, the company said. For FY26, consolidated n
Poonawalla Fincorp reports over fourfold rise in Q4FY26 net profit, supported by strong NII growth and nearly 70% increase in assets under management